Subcortical structural alterations have been implicated in the neuropathology of schizophrenia. Yet, the extent of anatomical alterations for subcortical structures across illness phases remains unknown. To assess this, magnetic resonance imaging (MRI) was used to examine volume differences of major subcortical structures: thalamus, nucleus accumbens, caudate, putamen, globus pallidus, amygdala and hippocampus. These differences were examined across four groups: (i) healthy comparison subjects (HCS, n ¼ 96); (ii) individuals at high risk (HR, n ¼21) for schizophrenia; (iii) early-course schizophrenia patients (EC-SCZ, n ¼28); and (iv) chronic schizophrenia patients (C-SCZ, n ¼20). Raw gray matter volumes and volumetric ratios (volume of specific structure/total gray matter volume) were extracted using automated segmentation tools. EC-SCZ group exhibited smaller bilateral amygdala volumetric ratios, compared to HCS and HR subjects. Findings did not change when corrected for age, level of education and medication use. Amygdala raw volumes did not differ among groups once adjusted for multiple comparisons, but the smaller amygdala volumetric ratio in EC-SCZ survived Bonferroni correction. Other structures were not different across the groups following Bonferroni correction. Smaller amygdala volumes during early illness course may reflect pathophysiologic changes specific to illness development, including disrupted salience processing and acute stress responses.
Illness stage Neuroimaging Chronic Structural a b s t r a c t
Subcortical structural alterations have been implicated in the neuropathology of schizophrenia. Yet, the extent of anatomical alterations for subcortical structures across illness phases remains unknown. To assess this, magnetic resonance imaging (MRI) was used to examine volume differences of major subcortical structures: thalamus, nucleus accumbens, caudate, putamen, globus pallidus, amygdala and hippocampus. These differences were examined across four groups: (i) healthy comparison subjects (HCS, n ¼ 96); (ii) individuals at high risk (HR, n ¼21) for schizophrenia; (iii) early-course schizophrenia patients (EC-SCZ, n ¼28); and (iv) chronic schizophrenia patients (C-SCZ, n ¼20). Raw gray matter volumes and volumetric ratios (volume of specific structure/total gray matter volume) were extracted using automated segmentation tools. EC-SCZ group exhibited smaller bilateral amygdala volumetric ratios, compared to HCS and HR subjects. Findings did not change when corrected for age, level of education and medication use. Amygdala raw volumes did not differ among groups once adjusted for multiple comparisons, but the smaller amygdala volumetric ratio in EC-SCZ survived Bonferroni correction. Other structures were not different across the groups following Bonferroni correction. Smaller amygdala volumes during early illness course may reflect pathophysiologic changes specific to illness development, including disrupted salience processing and acute stress responses.
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Introduction
Schizophrenia is a severe chronic illness associated with psychosis, thought disorganization and cognitive impairment (Tamminga, 2009 ). The significant functional decline of patients and 0.55% global lifetime prevalence (Saha et al., 2005) make understanding schizophrenia neurobiology important from both scientific and clinical perspectives. While cortical dysfunction, specifically in the prefrontal cortex (PFC) and the temporal cortex, is thought to be responsible for cognitive deficits and hallucinations (Barch et al., 2003; Deserno et al., 2012; Jardri et al., 2011; Tan et al., 2005) , complementary studies have increasingly documented significant impairments in emotion processing, with nodes of dysfunction located in subcortical regions (Dowd and Barch, 2010; Nielsen et al., 2012; Pinkham et al., 2011; Schlagenhauf et al., 2014) . For instance, abnormal amygdala function in response to emotional faces and decreased blood-oxygen level dependent (BOLD) activation in the ventral striatum during reward processing have been demonstrated in patients with schizophrenia compared to healthy controls (Anticevic et al., 2012b; Pinkham et al., 2011; Schlagenhauf et al., 2014) . Such functional alterations are likely linked to structural abnormalities of subcortical nuclei, and these local changes in structure and function may ultimately be reflected in the disruption of large-scale neural networks in patients with schizophrenia (Anticevic et al., 2014a; Cole et al., 2011; Meda et al., 2009 
